STRS Ohio’s Marrone Bio Innovations, Inc. MBII Stock Holding History

STRS Ohio’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-1,000	Closed	-$15.7K	–	1775
2013 Q4	$18K	Sell	1,000 -1,500	-60%	-$24.4K	﹤0.01%	1710
2013 Q3	$42K	Buy	+2,500	New	+$35.1K	﹤0.01%	1742

Other funds holding MBII

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

STRS Ohio's MBII Position: Q1 2014 in Review

STRS Ohio sold out of Marrone Bio Innovations, Inc. (MBII) in Q1 2014, closing a stake of 1,000 shares — an estimated $15.7K sold.

STRS Ohio first reported a position in MBII in Q3 2013 and held it in 2 quarters. The position peaked at $42K in Q3 2013. 48 funds tracked by Wall St. Rank hold MBII as of Q1 2014.

STRS Ohio reported no remaining Marrone Bio Innovations, Inc. position as of Q1 2014 after selling out during the quarter.
STRS Ohio sold 1,000 Marrone Bio Innovations, Inc. shares in Q1 2014, an estimated $15.7K.
STRS Ohio first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 2 quarters.
STRS Ohio's Marrone Bio Innovations, Inc. position peaked at $42K in Q3 2013.
48 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q1 2014.

Based on STRS Ohio's 13F filing for Q1 2014, filed 28 Apr 2014.